BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 19549571)

  • 21. Enhancement of prostacyclin production in cultured bovine aortic endothelial cells by oxidized glycated low-density lipoprotein.
    Kobayashi K; Watanabe J; Umeda F; Taniguchi S; Masakado M; Yamauchi T; Nawata H
    Prostaglandins Leukot Essent Fatty Acids; 1995 Apr; 52(4):263-70. PubMed ID: 7784476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supression of hemin-mediated oxidation of low-density lipoprotein and subsequent endothelial reactions by hydrogen sulfide (H(2)S).
    Jeney V; Komódi E; Nagy E; Zarjou A; Vercellotti GM; Eaton JW; Balla G; Balla J
    Free Radic Biol Med; 2009 Mar; 46(5):616-23. PubMed ID: 19100829
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyunsaturated fatty acid enrichment enhances endothelial cell-induced low-density-lipoprotein peroxidation.
    Mazière C; Dantin F; Conte MA; Degonville J; Ali D; Dubois F; Mazière JC
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):57-62. PubMed ID: 9806884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of curcumin on down-expression of thrombospondin-4 induced by oxidized low-density lipoprotein in mouse macrophages.
    Zhou ZY; Chen YQ; Wang FY; Tian N; Fan CL
    Biomed Mater Eng; 2014; 24(1):181-9. PubMed ID: 24211897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial cells prevent accumulation of lipid hydroperoxides in low-density lipoprotein.
    Smalley DM; Hogg N; Kalyanaraman B; Pritchard KA
    Arterioscler Thromb Vasc Biol; 1997 Dec; 17(12):3469-74. PubMed ID: 9437194
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of human low density lipoprotein oxidation by active principles from spices.
    Naidu KA; Thippeswamy NB
    Mol Cell Biochem; 2002 Jan; 229(1-2):19-23. PubMed ID: 11936843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of flavonoids on the susceptibility of low-density lipoprotein to oxidative modification.
    Safari MR; Sheikh N
    Prostaglandins Leukot Essent Fatty Acids; 2003 Jul; 69(1):73-7. PubMed ID: 12878454
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk?
    Verhoye E; Langlois MR;
    Clin Chem Lab Med; 2009; 47(2):128-37. PubMed ID: 19099526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-methyltetrahydrofolic acid stimulates endothelin-1 production in low density lipoprotein-treated human endothelial cells.
    Ronco AM; Llanos M; Tamayo D; Hirsch S
    Nutr Metab Cardiovasc Dis; 2007 Mar; 17(3):188-94. PubMed ID: 17367704
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oxysterols and TBARS are among the LDL oxidation products which enhance thromboxane A2 synthesis by platelets.
    Mahfouz MM; Kummerow FA
    Prostaglandins Other Lipid Mediat; 1998 Jul; 56(4):197-217. PubMed ID: 9777653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation between oxidation of low density lipoproteins and prostacyclin synthesis in cultured smooth muscle cells.
    Ek B; Humble L
    Biochem Pharmacol; 1991 Mar; 41(5):695-9. PubMed ID: 1900157
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamic AFM detection of the oxidation-induced changes in size, stiffness, and stickiness of low-density lipoprotein.
    Wang K; Li Y; Luo C; Chen Y
    J Nanobiotechnology; 2020 Nov; 18(1):167. PubMed ID: 33183326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease.
    Mosca L; Rubenfire M; Tarshis T; Tsai A; Pearson T
    Am J Cardiol; 1997 Oct; 80(7):825-30. PubMed ID: 9381992
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxidized low-density lipoprotein and atherosclerosis.
    Steinberg D; Witztum JL
    Arterioscler Thromb Vasc Biol; 2010 Dec; 30(12):2311-6. PubMed ID: 21084697
    [No Abstract]   [Full Text] [Related]  

  • 35. Estradiol 17beta inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees.
    Zhu X; Bonet B; Knopp RH
    Atherosclerosis; 2000 Jan; 148(1):31-41. PubMed ID: 10580168
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oxidized HDL are much less cytotoxic to lymphoblastoid cells than oxidized LDL.
    Alomar Y; Nègre-Salvayre A; Levade T; Valdiguié P; Salvayre R
    Biochim Biophys Acta; 1992 Oct; 1128(2-3):163-6. PubMed ID: 1420286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Discrimination between minimally modified LDL and fully oxidized LDL using monoclonal antibodies.
    Lowhalidanon K; Khunkaewla P
    Anal Biochem; 2021 Apr; 619():114103. PubMed ID: 33453163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein-X reduces LDL atherogenicity in primary biliary cirrhosis by preventing LDL oxidation.
    Chang PY; Lu SC; Su TC; Chou SF; Huang WH; Morrisett JD; Chen CH; Liau CS; Lee YT
    J Lipid Res; 2004 Nov; 45(11):2116-22. PubMed ID: 15314101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antioxidant potentials of furanodihydrobenzoxanthones from Artocarpus elasticus and their protection against oxLDL induced injury in SH-SY5Y cells.
    Baiseitova A; Shah AB; Khan AM; Idrees M; Kim JH; Lee YH; Kong IK; Park KH
    Biomed Pharmacother; 2023 Sep; 165():115278. PubMed ID: 37536031
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic reactions of oxidized LDL on cells of acute myeloid leukemia.
    Vahrenwald F; Galka K; Jürgens G; Bruchelt G; Girgert R; Schweizer P
    Leuk Res; 1997; 21(11-12):1071-6. PubMed ID: 9444941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.